(Q22337119)

7 February 2023

Joel N Hirschhorn

1

Joel N.

Hirschhorn

1 reference

1009382219

7 February 2023

Edward Byrne

series ordinal

3

author given names

Edward

author last names

Byrne

1 reference

1009382219

7 February 2023

Kurt Hirschhorn

series ordinal

4

author given names

Kurt

author last names

Hirschhorn

1 reference

1009382219

https://scigraph.springernature.com/pub.10.1097/00125817-200203000-00002

7 February 2023

language of work or name

English

0 references

publication date

April 2002

0 references

published in

Genetics in Medicine

0 references

volume

4

0 references

page(s)

45-61

0 references

issue

2

0 references

exact match

0 references

cites work

Genetic dissection of complex traits

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

Searching for genetic determinants in the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

Mutation in blood coagulation factor V associated with resistance to activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

Prevalence of the prothrombin 20210 G-to-A variant in blacks: infants, patients with venous thrombosis, patients with myocardial infarction, and control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

Susceptibility to spina bifida; an association study of five candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

Genetic Polymorphisms and Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

Association study designs for complex diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

Use of unlinked genetic markers to detect population stratification in association studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

Genomic control for association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

Detecting association in a case-control study while correcting for population stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

Association mapping in structured populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

Tests and estimates of allelic association in complex inheritance

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

The Pro12 -->Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

Impact of the Peroxisome Proliferator Activated Receptor γ2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

7 January 2021

Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

7 January 2021

Population genetics--making sense out of sequence

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

7 January 2021

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

1 reference

7 January 2021

The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

7 January 2021

Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

7 January 2021

Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

7 January 2021

Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200203000-00002

7 January 2021